Brunn Carsten
SEC CIK 1760229 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Pres, CEO, Dir | 323.5K | — | $725.6K | 28 | 2021-09-01 | 2026-01-06 |
Most active insiders at RNAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BARABE TIMOTHY C | Dir | $205.8K | — |
| 2 | Brunn Carsten | Pres, CEO, Dir | — | $162.1K |
| 3 | Davis Blaine | CFO | — | $72.2K |
| 4 | Miljkovic Milos | Chief Medical Off | — | $24.4K |
| 5 | Bot Adrian Ion | Dir | — | — |
| 6 | Seymour June Ann | CAO | — | — |
| 7 | English Emily | Chief Ops Off | — | — |
| 8 | Hoge Elizabeth | 10% | — | — |
| 9 | Singer Michael | Dir | — | — |
| 10 | Kalayoglu Murat | Dir, 10% | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | 2026-01-06 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $6.82 | -23.8K | 323.5K | -7% | -$162.1K | |
| D | 2026-01-06 | 2026-01-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +143.2K | 347.3K | +70% | $0 |
| M | 2025-01-07 | 2025-01-03+ | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $16.78 | -17.3K | 204.1K | -8% | -$289.7K |
| D | 2025-01-06 | 2025-01-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +57.5K | 221.4K | +35% | $0 |
| D | 2024-01-04 | 2024-01-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +4.65M | 4.92M | +1,777% | $0 |
| DM | 2023-11-15 | 2023-11-13 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | D - Sale to Iss | $2.06 | -521.1K | 544.8K | -49% | -$1.07M |
| 2023-09-26 | 2023-09-25 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.06 | -2,932 | 783.1K | -0.4% | -$3,108 | |
| M | 2023-01-06 | 2023-01-04+ | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.13 | -41.1K | 786.0K | -5% | -$46.4K |
| D | 2023-01-04 | 2023-01-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +282.8K | 827.1K | +52% | $0 |
| 2022-12-07 | 2022-12-05 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.33 | -4,522 | 544.3K | -0.8% | -$6,014 | |
| D | 2022-12-05 | 2022-12-01 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 548.8K | +2% | $0 |
| 2022-09-30 | 2022-09-28 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.66 | -2,692 | 537.9K | -0.5% | -$4,469 | |
| D | 2022-09-06 | 2022-09-01 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 545.3K | +2% | $0 |
| D | 2022-09-06 | 2022-09-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $1.85 | -4,768 | 540.6K | -0.9% | -$8,821 |
| D | 2022-06-03 | 2022-06-01 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 534.4K | +2% | $0 |
| D | 2022-03-03 | 2022-03-01 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 528.9K | +2% | $0 |
| D | 2022-03-03 | 2022-03-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $1.81 | -5,443 | 523.5K | -1% | -$9,852 |
| 2022-01-07 | 2022-01-05 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $3.09 | -13.6K | 518.0K | -3% | -$42.0K | |
| D | 2022-01-05 | 2022-01-03 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +226.3K | 531.6K | +74% | $0 |
| 2021-12-14 | 2021-12-10 | RNAC | Cartesian Therapeutics, Inc. | Pres, CEO, Dir | S - Sale | $2.99 | -17.2K | 305.3K | -5% | -$51.4K | ||
| 2021-12-10 | 2021-12-08 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +37.5K | 322.5K | +13% | $0 | |
| D | 2021-12-03 | 2021-12-01 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 289.7K | +4% | $0 |
| D | 2021-12-03 | 2021-12-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $2.96 | -4,746 | 285.0K | -2% | -$14.0K |
| 2021-10-15 | 2021-10-13 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale | $4.39 | -15.3K | 278.8K | -5% | -$67.2K | |
| 2021-10-05 | 2021-10-01 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +37.5K | 294.1K | +15% | $0 | |
| D | 2021-09-28 | 2021-09-24 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | A - Grant | $0.00 | +27.2K | 256.6K | +12% | $0 |
| D | 2021-09-03 | 2021-09-02 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $4.51 | -4,523 | 229.4K | -2% | -$20.4K |
| D | 2021-09-03 | 2021-09-01 | RNAC | Cartesian Therapeutics, Inc. | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 233.9K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations